NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Aesculap Inc., Ascendco Health Announce Strategic Partnership

Aesculap Inc. has announced a strategic partnership with Ascendco Health, an emerging health tech company.

“Combining industry-leading expertise with innovative technology, Aesculap Inc. powered by Ascendco Health’s proprietary technology provides an unparalleled solution for modernizing surgical operations,” according to a news release.

In today’s health care environment, hospital leadership is constantly challenged to identify ways to eliminate waste, reduce costs and improve efficiency.

The combination of Aesculap’s highly regarded sterile processing solutions and medical device expertise along with Ascendco’s competency in aggregating hospital data and converting it into useful analytics creates substantial value for U.S. health systems in their quest to reduce waste and operate more efficiently, according to the release.

“Partnering with Ascendco to deliver this transformative value to our customers aligns tightly with Aesculap’s core values and mission,” said Charles DiNardo, president of Aesculap Inc. “This is a great demonstration of Aesculap’s commitment to collaborative excellence through a culture of sharing expertise among our employees, partners, providers and patients.”

Aesculap’s Surgical Asset Management with its proven methodology has generated efficiencies through standardization and optimization opportunities for over 150 U.S. hospitals. The synergies created through the collaboration with Ascendco’s capabilities in data analytics and visualization will provide customers with the information required to sustain standardization and optimization efforts.

“Ascendco is excited to partner with Aesculap, introducing a combined suite of data and optimization tools that are so richly needed by our customers to help them make informed decisions around their surgical inventory and perioperative workspaces,” remarked Brian Reed, CEO, Ascendco Health.

For more information, visit aesculapusa.com or ascendcohealth.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X